CVE:ADK DIAGNOS (ADK) Stock Price, News & Analysis C$0.27 0.00 (0.00%) As of 08/29/2025 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartInsider TradesBuy This Stock About DIAGNOS Stock (CVE:ADK) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DIAGNOS alerts:Sign Up Key Stats Today's RangeC$0.26▼C$0.2850-Day RangeC$0.19▼C$0.2952-Week RangeC$0.18▼C$0.42Volume300,500 shsAverage Volume184,064 shsMarket CapitalizationC$27.50 millionP/E RatioN/ADividend Yield0.29%Price TargetN/AConsensus RatingN/A Company Overview DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada. Read More Receive ADK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ADK Stock News HeadlinesDIAGNOS Inc.: DIAGNOS Files FDA Pre-Submission for its CARA System: Strategic Entry into the U.S. Optometry Market with Support from ORA LLCJuly 16, 2025 | finanznachrichten.deDIAGNOS Inc. (DGNOF) Latest Press Releases & Corporate News - Yahoo Finance CanadaJune 27, 2025 | ca.finance.yahoo.comEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.August 30 at 2:00 AM | Timothy Sykes (Ad)Diagnos taps Allele for capital markets, social media servicesMay 25, 2025 | investing.comDiagnos’ CARA System License Application Advances with Health CanadaApril 9, 2025 | msn.comDIAGNOS Opens First US Office in FloridaMarch 31, 2025 | markets.businessinsider.comDIAGNOS Second Quarter 2025 Earnings: Revenues DisappointNovember 23, 2024 | finance.yahoo.comDIAGNOS Announces Cross-listing of its Common Shares on the Frankfurt Stock ExchangeNovember 12, 2024 | finance.yahoo.comSee More Headlines ADK Stock Analysis - Frequently Asked Questions How have ADK shares performed this year? DIAGNOS's stock was trading at C$0.29 at the start of the year. Since then, ADK shares have decreased by 5.3% and is now trading at C$0.27. How do I buy shares of DIAGNOS? Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of DIAGNOS own? Based on aggregate information from My MarketBeat watchlists, some other companies that DIAGNOS investors own include DIAGNOS (DGNOF), Facedrive (FDVRF), New Found Gold (NFGC), Ackroo (AKR), BeWhere (BEW), BlueRush (BTV) and Grande West Transportation Group (BUS). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolCVE:ADK CIKN/A Webwww.diagnos.ca Phone+1-450-6788882FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$3.81 million Net Margins-2,185.67% Pretax MarginN/A Return on Equity144.50% Return on Assets-134.33% Debt Debt-to-Equity Ratio-355.56 Current Ratio1.09 Quick Ratio0.68 Sales & Book Value Annual SalesC$86.51 thousand Price / Sales317.92 Cash FlowC$0.00 per share Price / Cash Flow60.00 Book ValueC($0.01) per share Price / Book-24.31Miscellaneous Outstanding Shares101,863,000Free FloatN/AMarket CapC$27.50 million OptionableNot Optionable Beta-0.20 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (CVE:ADK) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DIAGNOS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DIAGNOS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.